New study aims to predict dangerous clot complications early

NCT ID NCT07491094

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 400 adults diagnosed with pulmonary embolism (a blood clot in the lungs) at a Swedish hospital. Researchers will repeatedly check heart tests and blood markers during the first 48 hours to see if early changes can better predict who will worsen. The goal is to improve understanding and create a long-term follow-up system, not to test a new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to better ways to predict which patients with pulmonary embolism are at risk of getting worse, helping doctors make faster, more informed decisions.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve health. The findings may not apply to all hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sahlgrenska University Hospital/Mölndal

    NOT_YET_RECRUITING

    Gothenburg, Region Västra Götaland, Sweden

  • Sahlgrenska University Hospital/Sahlgrenska

    RECRUITING

    Gothenburg, Region Västra Götaland, Sweden

  • Sahlgrenska University Hospital/Östra

    NOT_YET_RECRUITING

    Gothenburg, Region Västra Götaland, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.